Archives des NEWS

Bachem Vionnaz: Fine chemistry capabilities, supporting complex API manufacturing

Integrated into the Bachem Group since 2001, the Vionnaz site brings over five decades of expertise in small molecule synthesis to Valais’ pharmaceutical manufacturing landscape. Its competencies in amino acid chemistry, electrochemistry and biocatalysis position it as a specialized contributor within Bachem’s global production network.

Bachem Vionnaz: Fine chemistry capabilities, supporting complex API manufacturing Read More »

Bioscibex reaches semi-finals of one of Switzerland’s leading startup competitions

Frédérique Brunner

Bioscibex, a biotech startup based at BioArk Monthey, has reached the semi-finals of the >>venture>> 2026 competition, one of Switzerland’s leading startup prizes.

Bioscibex reaches semi-finals of one of Switzerland’s leading startup competitions Read More »

Enhancing diagnostic sensitivity for real-world use

Frédérique Brunner

A recent ACS Sensors study shows how signal amplification improves the sensitivity of point-of-care diagnostic assays, enabling faster and more reliable detection of low-concentration biomarkers.

Enhancing diagnostic sensitivity for real-world use Read More »

New cross-border project targets antimicrobial resistance with AIEnhanced modified phages

Frédérique Brunner

A new cross-border project supported by the Interreg VI-A Italy–Switzerland program has been launched to address antimicrobial resistance (AMR), a growing challenge for healthcare systems.

New cross-border project targets antimicrobial resistance with AIEnhanced modified phages Read More »

Notrixx advances biomarker-based detection of bacterial contamination in pharmaceuticals

Frédérique Brunner

Notrixx, a startup from HES-SO Valais based in Sion, develops a biomarker-based test to improve detection of bacterial contamination in pharmaceuticals.

Notrixx advances biomarker-based detection of bacterial contamination in pharmaceuticals Read More »

Valsynthèse: Industrial Expertise in Fine and High-Risk Chemistry Rooted in Valais

Frédérique Brunner

Established in 1983 in Gamsen (Brig-Glis), Valsynthèse is a Valais-based company specializing in fine chemical synthesis and high-risk chemical processes. As a subsidiary of Société Suisse des Explosifs (SSE), the company operates at the interface of complex chemistry, industrial safety, and custom manufacturing for demanding applications.

Valsynthèse: Industrial Expertise in Fine and High-Risk Chemistry Rooted in Valais Read More »

Digital Life Sciences: Turning artificial intelligence into applied solutions

Frédérique Brunner

Within the Digital Life Sciences programme at HES-SO Valais-Wallis, students learn to design applied AI systems through real-world projects. NutriGuard AI demonstrates how artificial intelligence can be integrated into life-science quality assessment workflows.

Digital Life Sciences: Turning artificial intelligence into applied solutions Read More »

Valais Cluster at Swiss Biotech Day 2026

Frédérique Brunner

Meet us at SC2-Valais Cluster ! BioArk will take part in Swiss Biotech Day 2026, taking place in Basel on May 4-5, 2026.

Valais Cluster at Swiss Biotech Day 2026 Read More »

BioArk_CEIDOS guest spearker 2025 Business Ideas Innosuisse

CEIDOS shares early market lessons at the Business Ideas event series in Sion

Frédérique Brunner

At the Business Ideas event in Sion, CEIDOS shared its journey from early support to industrial validation in advanced cell therapy manufacturing.

CEIDOS shares early market lessons at the Business Ideas event series in Sion Read More »

Lugaia AG at a Turning Point: Growth, Space Constraints and Strategic Choices

Frédérique Brunner

Founded in 2005 in Raron, Lugaia AG has grown from a small garage-based startup into one of the world’s leading suppliers of flexible containment solutions for the pharmaceutical and chemical industries. Supported in its early development by the Foundation The Ark, the company now serves international markets and faces new strategic decisions regarding its future expansion.

Lugaia AG at a Turning Point: Growth, Space Constraints and Strategic Choices Read More »

NEWS

Start typing and press enter to search